The annual report has been approved for publishing by the Board of Directors and the CEO and is subject to adoption at the Annual General Meeting on the 10th May 2019.
The annual accounts and consolidated accounts for the financial year 2018 are now available on the company’s website (www.synactpharma.com), on the Spotlight Stock Markets website (www.spotlightstockmarket.com) and at the company’s offices (c/o Medicon Village AB, Scheelevägen 2, SE-223 81 Lund).
For further information about SynAct Pharma AB, please contact:
Jeppe Øvlesen
CEO, SynAct Pharma AB
Telephone: +45 28 44 75 67
E-mail: [email protected]